中文   |   English
Dr. Alexander Smikodub Jr. M.D. PhD.

Dr. Alexander Smikodub Jr. MD. PhD. & UCTC

UNIQUE CELL TREATMENT CLINIC is a medical center the history of which goes back to 1994. For over 21 years the founder of our clinic Professor Alexander Smikodub Sr. was the head of the clinic developing and introducing unique methods of stem cell treatment. Now his son Alexander Smikodub Jr. continues this unique treatment commenced by his father. During the years of work our clinic has performed about 6 500 transplantations of fetal stem cells. Our treatment has helped prolong life, improve its quality and in many cases completely cure thousands of patients from all over the world (the USA, Italy, Germany, China, the Russian Federation, Poland, etc.), who had lost any hope for recovery.

UNIQUE CELL TREATMENT CLINIC professionals provide fetal stem cell treatment (in vivo), develop comprehensive treatment for severe acquired and hereditary diseases caused by or resulting in cell count reduction. Moreover, a wide range of conditions such as aging, infertility, menopause, chronic fatigue syndrome and functional disorders of internal organs are treated at our clinic.

The clinic has a license for all the stem cell treatment methods developed by Alexander Smikodub Sr., Alexander Smikodub Jr. and its other specialists. All the methods are protected by the patents of Ukraine, Russia, the USA and other countries. At the present time, a number of patents on fetal stem cell application for treatment of various diseases and conditions are considering in the patent offices of many countries.

In the BBC documentary our clinic was called the “Last Hope Clinic” because we treat and follow-up the most severe clinical cases from all over the world.

During many years of work UNIQUE CELL TREATMENT CLINIC (UCTC) has won international recognition in the branch of research and treatment of patients by unique methods with application of fetal stem cells (in vivo). Our achievements were awarded a number of certificates of international medical conferences and congresses. But the most valuable award for UNIQUE CELL TREATMENT CLINIC is successful treatment and recovery of our patients, their words of gratitude.

 

History of the clinic

UNIQUE CELL TREATMENT CLINIC has a glorious history connected with the invention of medicinal preparations based on fetal stem cells and their clinical application. Here we were the pioneers and remain the leaders.

The scientific potential of our center is the huge knowledge and experience of our specialists and staff, it is a great deal of information published all over the world, it is a big number of reports and lectures at various congresses and conferences, it is scientific degrees and dissertations defended by our employees. By February, 2009 the specialists of our center under the supervision of Professor Alexander Smikodub Sr. and later of his son Alexander Smikodub Jr. up to June, 2011, provided medical services to patients from all over the world under the EmCell trademark.

In June, 2011 the company EmCell Embryonic Tissue Center Ltd. was divided between its owners according to their shares. Dr. Alexander Smikodub Jr. restructured his clinical base into a separate clinic with a well-developed infrastructure and a modern laboratory. The clinic provides its services under the UNIQUE CELL TREATMENT CLINIC trademark.

However, despite all reorganization processes, the center still has a long scientific history, a wealth of clinical experience and thousands of grateful patients we helped.

Our scientific history

1987                Treatment of patients with cytostatic myelodepression and aplastic anemia (filing of patent application).

1991                Clinical trials and invention of acquired immune deficiency syndrome (AIDS) a HIV-infection treatment method; filing of

                       patent application in the USA (priority since 1993).

1992                Successful application of fetal stem cells (in vivo) in clinical trials for treatment of type 1 and 2 diabetes mellitus, filing

                       of patent application

1993...1994      Foundation of the Cell Therapy Clinic of the NationalMedicalUniversity (17 Solomenskaya Str., Kiev, Ukraine). Clinical trials

                       of cell transplants for treatment of different diseases and conditions. First Ukrainian patents granted. The beginning of

                       development of multiple sclerosis treatment methods.

1995                Application of fetal stem cells (in vivo) for treatment of amyotrophic lateral sclerosis. First efforts to apply different types

                       of cell suspensions for treatment of muscular dystrophies, in particular Duchenne Muscular Dystrophy

1998...2001      Greek, USA, Russian Federation and Ukrainian patents granted.

1999                Ministry of Healthcare of Ukraine approval of methodological recommendations on application of fetal stem cells in oncology,

                       developed by the clinic.

2000                Ministry of Healthcare of Ukraine approval of methodological recommendations on application of fetal stem cells in diabetes

                       treatment, developed by the clinic.

2001                Ministry of Healthcare of Ukraine approval of methodological recommendations on application of fetal stem cells in

                       hematology, developed by the clinic.

2002                “Most Innovative Work” Award granted by the Scientific Committee of the Annual Meeting of the Society of Medical

                       Innovations and Technology (SMIT) held in Oslo, Norway. The first Dutch patent granted. Ministry of Healthcare of Ukraine

                       approval of methodological recommendations on application of fetal stem cells in endocrinology, developed by the clinic.

2003                The second Dutch patent granted.

2004                Ukrainian and Russian Federation patents granted. Development and patenting of methods of intestine diseases treatment

                       (Crohn’s disease, non-specific ulcerative colitis, etc.). Working out of ethical norms on the work with human fetal cells

                       approved by the Ministry of Healthcare of Ukraine.

2005...2007      Extension of active clinical and scientific activities, participation in the numerous conferences and congresses, direct

                       participation in the work of international societies and associations, such as Cellular Therapy Society, Cell Transplant 

                       Society, Multinational Association of Supportive Care in Cancer, Society for Minimally Invasive Therapy, EASD.

2008                Development of methods of fetal cell suspensions application in surgical practice, in particular for treatment of 

                       erosive-ulcerative lesions of stomach and duodenum complicated by bleeding. Elaboration of patient surveillance that 

                       was declared the best at the 1-st Central European Congress on Surgery (Prague, Czech Republic).

2009                Ukrainian patents granted

2010                Beginning of different cell suspensions application for treatment of thermal injuries of various complexity and localization.

 

Biotechnology of stem cell isolation and storage

UNIQUE CELL TREATMENT CLINIC uses modern methods of fetal stem cell isolation, production and storage. We ourselves produce medicinal preparations based on fetal cell suspensions, test them and use for treatment and scientific researches. Creation of medicinal preparations based on fetal cell suspensions and treatment of patients by the same organization is a perfect combination that lets us be confident of high quality of the cell transplant and allows to reach the most positive results.

 

Biotechnological stages of work with medicinal preparations based on fetal cell suspension:

  1. Timely and safe collection of the best quality fetal material in specialized departments in compliance with the Ethical Committee requirements.
  2. Preparing of medicinal preparations based on fetal cell suspension and putting them into sterile containers.
  3. Safety and viability testing of medicinal preparations based on fetal cell suspension before cryopreservation.
  4. Programmed cryopreservation of cell transplants.
  5. Safety and viability testing of defrosted medicinal preparations based on fetal cell suspension before their use.
  6. Long-term storage of medicinal preparations based on fetal cell suspension in cryobanks.

 

Cell suspension bank

UNIQUE CELL TREATMENT CLINIC owns a modern cell suspension bank with high-tech equipment. It includes modern Dewar flasks and cryogenic banks (tanks) of large volumes with tens of thousands of fetal cell suspensions samples.